查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2138687

基因合成（GS）市場報告：趨勢、預測與競爭分析（至2035年）

Gene Synthesis Market Report: Trends, Forecast and Competitive Analysis to 2035
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

基因合成（GS）市場

受商業和學術研究市場雙重機會的驅動，全球基因合成（GS）市場前景光明。預計到2035年，全球GS市場規模將達到62億美元，高於2027年的15億美元，2027年至2035年的複合年成長率（CAGR）為16.3%。推動該市場成長的關鍵因素包括對合成DNA需求的不斷成長、個人化醫療應用的日益廣泛以及生物技術研究投入的增加。

  • 根據 Lucintel 的預測，按類型分類，1000 個鹼基對 (bp) 以下的類別預計將在預測期內呈現最高的成長率，因為外包小於 250 個鹼基對 (bp) 的短序列既便宜又快速。
  • 從應用領域來看，「商業」領域預計在預測期內將呈現更高的成長，這主要得益於生技公司基因合成（GS）外包業務的增加。
  • 從區域來看，亞太地區預計將在預測期內實現最高成長，這主要得益於該地區生物技術產業及相關企業的成長。

基因合成（GS）市場的新趨勢

2025年至2027年間，基因合成（GS）市場預計將經歷重大轉型，從合約實驗室轉向集中式、軟體控制的合成模式。自動化、定序成本降低以及製藥、科研、診斷、農業和工業生物技術領域對工程生物學日益成長的需求將推動這一成長。 Lucintel預測，關鍵競爭因素將包括前置作業時間管理、準確性、法規遵循以及設計與製造（D&M）系統的整合。

  • 自動化：液體處理、雲端工作流程和品管定序的自動化正在融入高通量定序平台。 Twist Bioscience公司2024會計年度營收達2.966億美元，顯示合成DNA市場呈現顯著成長。未來三到五年內，自動化將減少勞力密集工作，並支援建立更大規模、更全面的DNA文庫。
  • 人工智慧驅動的設計：設計軟體正日益篩檢更多功能，用於在合成前篩選所提供序列的可製造性、可表達性和風險。 2025年蛋白質和DNA設計模型的發布，將使設計軟體更加普及。預計訂單失敗率將下降，價值將轉移到相應的「設計」、「合成」和「檢驗」服務。
  • 更長更複雜的構建體：客戶對更長更複雜的構建體（例如通路和文庫）的需求持續成長，而對較短寡核苷酸的需求則保持平穩。至2025年，多家公司將開始提供千鹼基規模的基因組裝試劑盒。更長更複雜的構建體將顯著推動基因合成（GS）市場的擴張。這也將催生對更高保真度和無需糾錯方法的需求。
  • 生物安全：隨著合成DNA在更廣泛的客戶群中得到應用，佔全球商業基因合成產能80%以上的國際基因合成聯盟（IGSC）正逐步採用序列篩檢作為其服務提供者。到2030年，採購、資料交換和市場准入都將以既定的篩檢標準為基礎。
  • 區域生產能力：在生物製造領域，各國政府和投資者都在努力提升國內生產能力，而減少對集中式供應鏈網路的依賴是他們的共同目標。 2025年，人們對類似「歐洲晶片法案」的生物技術舉措以及美國聯邦生物經濟計畫的基礎設施建設資金越來越感興趣。雖然區域生產有助於緩解供應的不確定性，但高度競爭的市場環境可能會加劇價格和交貨時間的壓力。

基因合成（GS）正從一個小眾採購類別轉變為生物經濟的核心要素。能夠將設計自動化軟體和設備結合的供應商將滿足持續成長的需求。隨著產能的擴大，價格壓力將持續存在，但對於複雜的構建體和受監管的應用，高價仍然不可避免。客戶將主要根據資料完整性、生物安全性、可靠的交貨和技術支援來評估供應商。

基因合成（GS）市場近期趨勢

基因合成（GS）市場依然活躍，這主要得益於寡核苷酸價格的下降以及人工智慧在設計輔助上的應用。對生物工程日益成長的需求也是推動生產力計畫的重要因素。 Lucintel 認為，競爭對手的關注正從價格轉向交付速度、定序準確性、生物安全合規性以及確保可擴展的生產。市場投資仍將保持選擇性，科學研究、農業和製藥業的客戶將推動市場差異化。

  • 產能擴張：Twist Bioscience公佈2025會計年度第一季（2025年2月）銷售額達1.917億美元。市場對高通量DNA文庫及生物製劑藥物研發的強勁需求，主要得益於大規模生產設施的投產。這很可能導致小規模的區域性競爭對手湧現，他們將提供客製化序列和更專業的產品。
  • 技術應用：2025年，Integrated DNA Technologies (IDT) 擴展了其 xGen定序和合成生物學產品線，創造了超越傳統質體訂單的需求。未來3-5年，將設計軟體與合成、組裝和檢驗相結合的公司將佔最大的客戶支出佔有率。
  • 策略聯盟：2025年1月，NVIDIA與Illumina合作，旨在將雙方在基因組學領域的高速運算和生成式人工智慧技術優勢結合。隨著序列分析精度的提高預計將增加設計需求，進入合成市場的公司必須透過提供整合運算工具來應對這一趨勢。
  • 政府監管：美國計畫在2025年前加強對2022年生物技術和生物製造行政命令的監管和執行，從而加強對生物技術供應鏈的監控力度。這將增加所有公司的合規成本。然而，擁有客戶檢驗和序列監控系統的公司預計將獲得更大的市場佔有率。
  • 產業重組：賽默飛世爾科技（Thermo Fisher Scientific）的銷售額高達429億美元（截至2025年2月），在生命科學儀器產業中佔主導地位。雖然這筆交易並非純粹的基因合成交易，但產業重組及相關收購很可能在預測期內淘汰一些規模小規模的競爭對手。

由於人們對基因合成（GS）的信任度和依賴性不斷提高，以及對交貨和與自動化生物學融合的需求日益成長，基因合成市場將持續成長。在商業市場中，藥物研發仍將佔主導地位，而學術界的需求仍將對成本高度敏感。隨著客戶降低跨境交易風險，區域性生產將會增加。擁有篩檢、生產和設計軟體的供應商的利潤率將會提高。

目錄

第1章：摘要整理

第2章 市場概覽

  • 背景與分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 宏觀經濟趨勢與預測
  • 產業促進因素與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章 全球基因合成（GS）市場：依類型分類

  • 吸引力分析：按類型
  • 小於1000 bp
  • 1001～3000 bp
  • 3001～5000 bp
  • 超過5000 bp

第5章 全球基因合成（GS）市場：依應用領域分類

  • 吸引力分析：依目的
  • 商業
  • 學術研究

第6章 區域分析

第7章：北美基因合成（GS）市場

  • 北美基因合成（GS）市場：按類型分類
  • 北美基因合成（GS）市場：依應用領域分類
  • 美國基因合成（GS）市場
  • 加拿大基因合成（GS）市場
  • 墨西哥基因合成（GS）市場

第8章：歐洲基因合成（GS）市場

  • 歐洲基因合成（GS）市場：按類型分類
  • 歐洲基因合成（GS）市場：依應用領域分類
  • 德國基因合成（GS）市場
  • 法國基因合成（GS）市場
  • 義大利基因合成（GS）市場
  • 西班牙基因合成（GS）市場
  • 英國基因合成（GS）市場

第9章：亞太地區的基因合成（GS）市場

  • 亞太地區基因合成（GS）市場：依類型分類
  • 亞太地區基因合成（GS）市場：依應用領域分類
  • 中國的基因合成（GS）市場
  • 印度基因合成（GS）市場
  • 日本基因合成（GS）市場
  • 韓國基因合成（GS）市場
  • 印尼基因合成（GS）市場

第10章：其他地區的基因合成（GS）市場

  • 其他地區基因合成（GS）市場：依類型分類
  • 其他地區基因合成（GS）市場：依應用分類
  • 中東基因合成（GS）市場
  • 南美洲基因合成（GS）市場
  • 非洲基因合成（GS）市場

第11章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析
  • 市佔率分析

第12章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
  • 新趨勢：全球基因合成（GS）市場
  • 戰略分析

第13章：價值鏈中關鍵企業的公司概況

  • 競爭分析概述
  • GeneScript
  • Thermo Scientific
  • IDT
  • Eurofins Genomics
  • DNA 2.0
  • BBI
  • Azenta Life Sciences
  • SBS Genetech
  • Bio Basic
  • Twist Bioscience

第14章附錄

Gene Synthesis Market

The future of the global gene synthesis market looks promising with opportunities in the commercial and academic research markets. The global gene synthesis market is expected to reach an estimated $6.2 billion by 2035 from $1.5 billion in 2027 with a CAGR of 16.3% from 2027 to 2035. The major drivers for this market are the increasing demand for synthetic DNA, the rising applications in personalized medicine, and the growing investments in biotech research.

  • Lucintel forecasts that, within the type category, below 1000 bp is expected to witness the highest growth over the forecast period due to cheaper and faster outsourcing of short (less than 250 bp) sequences.
  • Within the application category, commercial is expected to witness higher growth over the forecast period due to expanding outsourcing of gene synthesis by biotech companies.
  • In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the growth of the biotech industry and related companies in the area.

Emerging Trends in Gene Synthesis Market

It is anticipated that between 2025 and 2027, the gene synthesis market will undergo a significant shift from custom laboratories to centralized and software controlled synthesis. Automation and a decrease in sequencing costs along with the predicted increase in demand for engineered biology in the Pharmaceutical, research, diagnostic, Agriculture, and Industrial Biotechnology sectors will drive market growth. Lucintel expects the main competition to be based on the control of turnaround time, accuracy, regulatory compliance, and integrated Design and Manufacturing systems.

  • Automation: Automation of liquid handling, cloud workflows, and quality control sequencing is being integrated into high-throughput foundries. Twist Bioscience reported revenue of $296.6 million for the fiscal year 2024, demonstrating a significant growth of the synthetic DNA market. In the next three to five years, automation will reduce the labor-intensive nature of the work and make larger and more extensive construct libraries available.
  • AI-enabled Design: Design software is incorporating the ability to screen for manufacturability, expressibility, and risk of supplied sequences prior to synthesis. The 2025 launch of protein design and DNA design models brought increased accessibility to design software. Failed orders will become less likely and the value will shift to design, synthesis, and validation as a service, respectively.
  • Longer and Complex Constructs: Customer requests for longer and more complex constructs like Pathways and Libraries continues to increase, while requests for shorter oligos remains static. In 2025, multiple companies started launching multi-kilobase Gene Assembly Kits. Longer and more complex constructs will drive a significant market increase for gene synthesis. This will also generate a demand for higher fidelity and lower error-correction methods.
  • Biosecurity: With synthetic DNA reaching more customer segments, the entire International Gene Synthesis Consortium, which represents over 80% of the world's commercial gene synthesis capacity, is implementing sequence screening as a provider. By 2030, procurement, data exchange, and market access will be underpinned by established screening standards.
  • Regional Capacity: Reduced reliance on concentrated supply networks is the goal of governments and biomanufacturing investors as they develop domestic capabilities. In 2025, infrastructure funding for the European Chips Act-like biotechnology initiatives and U.S. federal bioeconomy programs gained interest. While regional production will help mitigate supply uncertainty, competitive markets will increase pressure on prices and turn-around-times.

Gene synthesis is transforming from a niche purchasing category to a core element of the bioeconomy. Providers that combine design automation software with machinery will control repeat demand. During expansion of capacities, pricing pressure will persist, while advanced constructs and regulated applications will maintain a premium. Customers will primarily base their assessments of suppliers on data integrity, biosecurity, reliable deliveries, and technical assistance.

Recent Developments in the Gene Synthesis Market

Gene synthesis market activity continues to increase due to declining oligonucleotide prices and the use of AI to assist design. Increasing demand for engineered biology is also a strong driver for capacity planning. Lucintel believes the focus of competition will be on speed of delivery, accuracy of sequences, biosecurity compliance, and ensuring scalable manufacturing, not price. Investment in the market will continue to be selective, and customers from research, agriculture, and pharmaceuticals will drive market differentiation.

  • Capacity Expansion: Twist Bioscience reported revenue of $191.7 million for fiscal first-quarter 2025 (February 2025). The strong demand for high throughput DNA libraries and biologics discovery was attributed to opening larger production facilities. This will result in smaller, regional, competitors offering custom sequences and more specialized products.
  • Technology Launch: Integrated DNA Technologies (IDT) introduced expanded xGen sequencing and synthetic biology offerings in 2025, creating a demand for more than just traditional plasmid orders. In the next 3-5 years, companies that integrate design software with synthesis, assembly and validation will capture the largest portion of the customer spend.
  • Strategic Collaboration: NVIDIA and Illumina partnered in January 2025 to leverage their combined expertise in accelerated computing and generative AI in genomics. Better sequence interpretation will drive more design requests, and companies within the synthesis market must keep pace by offering integrated computational tools.
  • Government Oversight: The U.S. aims for 2025 to increase oversight and implementation of the 2022 Executive Order on biotechnology and biomanufacturing, thereby strengthening scrutiny on biotechnology supply chains. This will increase compliance costs for all companies. However, it should increase the market share of companies that have customer verification and sequence-monitoring systems.
  • Commercial Consolidation: Thermo Fisher Scientific has a dominant position in the life science tools industry with a $42.9 billion (reported in February 2025) revenue. While this particular case is not a purely gene-synthesis transaction, consolidation, and related procurement options, will drive the smaller competitors out of the industry in the forecast period.

The gene synthesis market will experience growth related to trust and reliance in delivery, and integration with automated biology. The dominant commercial market will continue to be pharmaceutical discovery, while the demand from academia will continue to be cost sensitive. Regional production will increase as customers reduce the risk of cross border trade. Margin share will increase for suppliers with screening, manufacturing and design software.

Strategic Growth Opportunities in the Gene Synthesis Market

The gene synthesis market is entering a new commercial period as companies start shifting their focus from building the first proof-of-concept tools and technologies to industrial solutions. Between the years 2024 and 2026, it is expected that falling costs of DNA, faster software, and more stringent screening will create a demand for consistent and reliable capacity. Lucintel believes that opportunity lies in the synthesis of quality sequences and application economy.

  • Therapeutic Construct Services: Custom genes for cell and gene therapy developers can attract a premium over research sequences. In January 2025, the FDA approved more than 40 cellular and gene therapy products. Demand will become more predictable and regulated as developers outsource the optimization and verification of constructs and the documentation of the process.
  • Industrial Biotechnology: Beyond the pharmaceutical market, enzyme libraries and pathway assemblies provide additional avenues for growth. In March 2025, Novo Nordisk reported 2024 sales of DKK 290.4 billion, highlighting that investments in biomanufacturing will remain strong. Large-scale programs for the production of specialty chemicals, biomaterials, and fermentation will likely grow.
  • Regional Manufacturing: Synthesis and delivery that can be localized will alleviate customs delays and concerns from data governance. In April 2025, the European Union comprised 27 member states and shared biotechnology funding mechanisms. Regional facilities will attract clients if they can meet very short lead times and screening requirements for various jurisdictions.
  • Premium Screened Sequences: Security-certified synthesis, audit trails, and detection of prohibited sequences provide a defensible service tier. The International Gene Synthesis Consortium (IGSC) with over 25 members, in June 2025, demonstrated a growing interest in secure biosecurity. With the increasing importance of biosecurity, the pursuit of documented, continuously screened suppliers will become the norm.
  • Digital Design Integration: Generating revenue through the integration of digital design and ordering, manufacturing, and quality control via APIs, is possible. In February 2025, NVIDIA reported revenue of $39.3 billion, reflecting growing investment in the advancement of computational biology. Integrated platforms will encapsulate spending on workflow and decrease customer attrition.

In the coming five years, the winning providers will sell workflows instead of individual oligonucleotides. The major revenue streams will shift toward regulated constructs, industrial biology, regional delivery, assurance of screening, and recurring service. Clients will reward providers who decrease design times and document provenance and performance. There will always be a need for a large provider, but smaller providers can protect their margins using application specific libraries and custom synthesis.

Gene Synthesis Market Drivers and Challenges

The gene synthesis market is defined by the dynamics of increasing customization, decreasing costs, and increasingly sophisticated biosecurity measures. Growing demand from pharmaceutical, agricultural, industrial and academic sectors for custom DNA is driven by competing needs to discover and innovate faster. Lucintel predicts that market success will balance innovation with affordability whilst addressing quality, compliance, security and sustainable access in global supply chains.

The factors responsible for driving this market include:

  • Customer Demand: Market growth is driven by growing customized gene, DNA library, plasmid, and pathway demand in the areas of drug discovery, diagnostics, agriculture and industrial biotechnology. In January 2025, millions of engineered DNA constructs continued to be used in biological research globally. In the next 3-5 years, market growth is expected to accelerate due to growing demand for outsourced synthesis. This is expected due to the reduced time, lab work, and errors in biological research. Growth is expected to be in the area of more complex constructs, variant libraries, and sequence modalities that facilitate newer and more tailored biological research.
  • Technology Advancements: Advancements in automation, artificial intelligence, and high-throughput assembly have made synthesis more precise and more able to produce longer and more complex sequences. By February 2025, most commercial providers started offering modular assembly and quality control workflows for constructs exceeding 100,000 base pairs. In the next three to five years, the market will see the positive effects of advancements in automation and synthetic biology. This will decrease the time it takes to synthesize sequences and make synthetic genomes and constructs for synthetic cells and synthetic pathways. Advancements in software will enable customers to synthesize and track their orders with a unified digital interface.
  • Pharmaceutical and Biotechnological Research: The demand for gene synthesis includes the fields of developing vaccines, therapeutics, and engineered biological systems. In March 2025, approximately 2,000 clinical studies for gene therapies and cellular therapies were ongoing around the world. This signifies a long-term demand for research-grade DNA and viral-vector components. In the next three to five years, this will influence the market since pharmaceutical companies will continue to fund the usage of synthetic genes to perform synthetic biology and expedite target validation, protein engineering, and the development of therapeutics with increased efficacy. This will drive an increase in funding for precision medicine, furthering the demand for custom high-quality, sequence-verified biomaterials.
  • Sustainability and Bioeconomy Expansion: Synthetic biology offers multiple opportunities for the lower-carbon production of chemicals, materials, fuels and food ingredients as well as agricultural inputs. By April of 2025, bio-based production focused on replacing petroleum-based products across multiple industrial sectors. In the coming three-to-five year period, this trend will affect the market as companies will need to invest in synthetic DNA to engineer microbes and optimize biological production pathways. Manufacturers will make this investment as companies shift toward renewable feedstocks and lower energy consumption, generate less waste, and create more resilient supply chains. In addition, sustainable procurement practices may favor suppliers who use improved synthesis technologies and marginal impact laboratory operations.
  • Manufacturing Efficiency and Cost-Advantages: Lowering per base costs and production run consistency is accelerated by larger manufacturing facilities, automation of purification, standardized work flows, and regional fulfillment. By May of 2025, high throughput providers had developed manufacturing systems that automated the processing of thousands of individual DNA orders per day. This trend will affect the market during the coming three-to-five years as gene synthesis services will become available to smaller academic centers and agri-tech companies. This decrease in cost will enable more innovative design approaches, while faster delivery will decrease project completion times. Given these changes, suppliers will need to focus on maintaining product quality.

The challenges facing this market include:

  • Biosecurity and Regulatory Compliance: Gene synthesis vendors must screen customer identity, sequence, and review hazardous biological content. Further, they must comply with various laws of different countries. In June 2025, deliberations focused on the harmonization of the screening of synthetic DNA providers across various jurisdictions. This issue will shape the Market in the next 3-5 years, while the Market matures, as the need for more oversight increases the compliance cost and the time to review orders. Effective screening, however, helps to build and maintain public confidence and prevents market misuse. The Market is likely to be dominated by vendors with automated risk assessment systems and secure databases.
  • Technical Complexity and Quality Control: The accurate synthesis of long, repetitive, toxic, or GC-rich sequences is challenging and may require succession, assembly, or validation. In July 2025, multiple quality-control checks, including sequencing and restriction analysis, were required for the use of complex constructs in research. In the next 3-5 years, this issue will impact the Market with customer expectation for longer sequences and constructs of complete pathways. Failure to synthesize will increase costs and delay development. Providers must make substantial investments in synthesis, redesign, and assembly, as well as new methods of error correction and instrumentation.
  • Supply Chain, Pricing, and Competitive Pressure: Gene synthesis is a complicated process that requires specialized reagents and enzymes, equipment, a workforce, data infrastructure and logistics, and relies on supply chain networks. As of August 2025, laboratories throughout different regions reported significant lead times of weeks for sourcing specific Biotech inputs. Over the next 3-5 years, this is anticipated to stimulate the market as the risk of disruptions, currency shifts, tariffs, and aggressive competing prices brings margins down and unreliable supply. Smaller vendors will struggle to fund advanced automation and quality systems. Regional production, additional vendor sourcing, inventory management, and complex-sequence services will become necessary.

Customized DNA synthesis is expected to increase with the anticipated growth in biotech, pharma, industrial bio, and sustainable business initiatives. Improving technology and manufacturing at scale is expected to decrease the cost and increase the speed and complexity of sequences. However, gene synthesis will likely be limited by biosecurity concerns, disrupted supplies, and competing prices. Offering automation and quality assurance services to clients combined with secure screening and regulations will give providers a competitive edge. The future of the market will depend on sustaining the balance between affordability, safety, and reliability while ensuring responsible access to complex genetic materials for clients of all kinds.

List of Gene Synthesis Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies gene synthesis market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the gene synthesis market companies profiled in this report include-

  • GenScript
  • Thermo Scientific
  • IDT
  • Eurofins Genomics
  • DNA 2.0
  • BBI
  • Azenta Life Sciences
  • SBS Genetech
  • Bio Basic
  • Twist Bioscience

Gene Synthesis Market by Segment

The study includes a forecast for the global gene synthesis market by type, application, and region.

Gene Synthesis Market by Type [Value ($B) from 2019 to 2035]:

  • Below 1000 bp
  • 1001-3000 bp
  • 3001-5000 bp
  • Above 5000 bp

Gene Synthesis Market by Application [Value ($B) from 2019 to 2035]:

  • Commercial
  • Academic Research

Gene Synthesis Market by Region [Value ($B) from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Gene Synthesis Market

The gene synthesis market for 2025 to 2027 shows an increase in demand due to biomanufacturing, genomic medicine, and national biotechnology strategies with a more dispersed geographical capacity investment. According to Lucintel's latest market assessment, supplier execution and policy support will remain vital to market development.

  • United States: The Federal government supports continued domestic manufacturing with a focus on the All of Us Research Program. In January 2025, the National Institutes of Health indicated that the program had reached 900,000 participants, establishing a stronger foundation for the country's genomic research with Twist Bioscience and Integrated DNA Technologies continuing to fund high-throughput oligonucleotide and gene-production programs. It is anticipated that the investments will sustain buying activity from pharmaceutical, academic, and synthetic-biology clients for the next three to five years.
  • China: Local capacities for sequencing and synthesis remain dominant in the national biotechnology priorities. BGI's 2024 report, published in March 2025, indicated that the company generated over RMB3.1 billion in revenue for the year, while GenScript maintained integrated gene, protein, and cell therapy manufacturing. The combination of local suppliers and public sector genomic programs will further support local procurement and lessen the reliance on imported research supplies.
  • Germany: Funding for industrial biotechnology and pharmaceutical production is maintained on a pan-European and national level. In February 2025, BioNTech reported €2.75 billion in 2024 revenues and continued spending on the development of its mRNA technology and personalized immunotherapy that requires dedicated DNA constructs. This makes sure that the requirements for compliant and quality manufacturing of DNA synthesis are fulfilled. It secures Germany's position in regulated life-science production within the European Union.
  • India: Increasing population genomics infrastructures. January 2025, the Genome India project reportedly made 10,000 genomes project data available to researchers for domestic assay, diagnostic, and research use. This will create demand for synthetic DNA and its associated quality controls.
  • Japan: Precision medicine and biopharmaceutical initiatives are continued to be prioritized by the government. March 2025, Takara Bio reported the fiscal year 2025 revenue of ¥46.3 billion with continued investments in DNA and RNA synthesis and gene editing as well as gene manufacturing technologies. It will create an ongoing need for reliable synthesis in academic, diagnostic, and pharmaceutical laboratories.

Features of the Global Gene Synthesis Market

  • Market Size Estimates: gene synthesis market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
  • Segmentation Analysis: gene synthesis market size by type, application, and region in terms of value ($B).
  • Regional Analysis: gene synthesis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the gene synthesis market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the gene synthesis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the gene synthesis market by type (below 1000 bp, 1001-3000 bp, 3001-5000 bp, and above 5000 bp), application (commercial and academic research), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Gene Synthesis Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Below 1000 bp : Trends and Forecast 2019 to 2035
  • 4.4 1001-3000 bp : Trends and Forecast 2019 to 2035
  • 4.5 3001-5000 bp : Trends and Forecast 2019 to 2035
  • 4.6 Above 5000 bp : Trends and Forecast 2019 to 2035

5. Global Gene Synthesis Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Commercial : Trends and Forecast 2019 to 2035
  • 5.4 Academic Research : Trends and Forecast 2019 to 2035

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Gene Synthesis Market by Region

7. North American Gene Synthesis Market

  • 7.1 Overview
  • 7.2 North American Gene Synthesis Market by Type
  • 7.3 North American Gene Synthesis Market by Application
  • 7.4 The United States Gene Synthesis Market
  • 7.5 Canadian Gene Synthesis Market
  • 7.6 Mexican Gene Synthesis Market

8. European Gene Synthesis Market

  • 8.1 Overview
  • 8.2 European Gene Synthesis Market by Type
  • 8.3 European Gene Synthesis Market by Application
  • 8.4 German Gene Synthesis Market
  • 8.5 French Gene Synthesis Market
  • 8.6 Italian Gene Synthesis Market
  • 8.7 Spanish Gene Synthesis Market
  • 8.8 The United Kingdom Gene Synthesis Market

9. APAC Gene Synthesis Market

  • 9.1 Overview
  • 9.2 APAC Gene Synthesis Market by Type
  • 9.3 APAC Gene Synthesis Market by Application
  • 9.4 Chinese Gene Synthesis Market
  • 9.5 Indian Gene Synthesis Market
  • 9.6 Japanese Gene Synthesis Market
  • 9.7 South Korean Gene Synthesis Market
  • 9.8 Indonesian Gene Synthesis Market

10. ROW Gene Synthesis Market

  • 10.1 Overview
  • 10.2 ROW Gene Synthesis Market by Type
  • 10.3 ROW Gene Synthesis Market by Application
  • 10.4 Middle Eastern Gene Synthesis Market
  • 10.5 South American Gene Synthesis Market
  • 10.6 African Gene Synthesis Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunity by Type
    • 12.2.2 Growth Opportunity by Application
  • 12.3 Emerging Trends in the Global Gene Synthesis Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis Overview
  • 13.2 GeneScript
    • Company Overview
    • Gene Synthesis Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Thermo Scientific
    • Company Overview
    • Gene Synthesis Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 IDT
    • Company Overview
    • Gene Synthesis Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Eurofins Genomics
    • Company Overview
    • Gene Synthesis Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 DNA 2.0
    • Company Overview
    • Gene Synthesis Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 BBI
    • Company Overview
    • Gene Synthesis Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Azenta Life Sciences
    • Company Overview
    • Gene Synthesis Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 SBS Genetech
    • Company Overview
    • Gene Synthesis Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Bio Basic
    • Company Overview
    • Gene Synthesis Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Twist Bioscience
    • Company Overview
    • Gene Synthesis Market Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Gene Synthesis Market
  • Figure 2.1: Usage of Gene Synthesis Market
  • Figure 2.2: Classification of the Global Gene Synthesis Market
  • Figure 2.3: Supply Chain of the Global Gene Synthesis Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the Gene Synthesis Market
  • Figure 4.1: Global Gene Synthesis Market by Type in 2019, 2026, and 2035
  • Figure 4.2: Trends of the Global Gene Synthesis Market ($B) by Type
  • Figure 4.3: Forecast for the Global Gene Synthesis Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Below 1000 bp in the Global Gene Synthesis Market (2019-2035)
  • Figure 4.5: Trends and Forecast for 1001-3000 bp in the Global Gene Synthesis Market (2019-2035)
  • Figure 4.6: Trends and Forecast for 3001-5000 bp in the Global Gene Synthesis Market (2019-2035)
  • Figure 4.7: Trends and Forecast for Above 5000 bp in the Global Gene Synthesis Market (2019-2035)
  • Figure 5.1: Global Gene Synthesis Market by Application in 2019, 2026, and 2035
  • Figure 5.2: Trends of the Global Gene Synthesis Market ($B) by Application
  • Figure 5.3: Forecast for the Global Gene Synthesis Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Commercial in the Global Gene Synthesis Market (2019-2035)
  • Figure 5.5: Trends and Forecast for Academic Research in the Global Gene Synthesis Market (2019-2035)
  • Figure 6.1: Trends of the Global Gene Synthesis Market ($B) by Region (2019-2026)
  • Figure 6.2: Forecast for the Global Gene Synthesis Market ($B) by Region (2027-2035)
  • Figure 7.1: Trends and Forecast for the North American Gene Synthesis Market (2019-2035)
  • Figure 7.2: North American Gene Synthesis Market by Type in 2019, 2026, and 2035
  • Figure 7.3: Trends of the North American Gene Synthesis Market ($B) by Type (2019-2026)
  • Figure 7.4: Forecast for the North American Gene Synthesis Market ($B) by Type (2027-2035)
  • Figure 7.5: North American Gene Synthesis Market by Application in 2019, 2026, and 2035
  • Figure 7.6: Trends of the North American Gene Synthesis Market ($B) by Application (2019-2026)
  • Figure 7.7: Forecast for the North American Gene Synthesis Market ($B) by Application (2027-2035)
  • Figure 7.8: Trends and Forecast for the United States Gene Synthesis Market ($B) (2019-2035)
  • Figure 7.9: Trends and Forecast for the Mexican Gene Synthesis Market ($B) (2019-2035)
  • Figure 7.10: Trends and Forecast for the Canadian Gene Synthesis Market ($B) (2019-2035)
  • Figure 8.1: Trends and Forecast for the European Gene Synthesis Market (2019-2035)
  • Figure 8.2: European Gene Synthesis Market by Type in 2019, 2026, and 2035
  • Figure 8.3: Trends of the European Gene Synthesis Market ($B) by Type (2019-2026)
  • Figure 8.4: Forecast for the European Gene Synthesis Market ($B) by Type (2027-2035)
  • Figure 8.5: European Gene Synthesis Market by Application in 2019, 2026, and 2035
  • Figure 8.6: Trends of the European Gene Synthesis Market ($B) by Application (2019-2026)
  • Figure 8.7: Forecast for the European Gene Synthesis Market ($B) by Application (2027-2035)
  • Figure 8.8: Trends and Forecast for the German Gene Synthesis Market ($B) (2019-2035)
  • Figure 8.9: Trends and Forecast for the French Gene Synthesis Market ($B) (2019-2035)
  • Figure 8.10: Trends and Forecast for the Spanish Gene Synthesis Market ($B) (2019-2035)
  • Figure 8.11: Trends and Forecast for the Italian Gene Synthesis Market ($B) (2019-2035)
  • Figure 8.12: Trends and Forecast for the United Kingdom Gene Synthesis Market ($B) (2019-2035)
  • Figure 9.1: Trends and Forecast for the APAC Gene Synthesis Market (2019-2035)
  • Figure 9.2: APAC Gene Synthesis Market by Type in 2019, 2026, and 2035
  • Figure 9.3: Trends of the APAC Gene Synthesis Market ($B) by Type (2019-2026)
  • Figure 9.4: Forecast for the APAC Gene Synthesis Market ($B) by Type (2027-2035)
  • Figure 9.5: APAC Gene Synthesis Market by Application in 2019, 2026, and 2035
  • Figure 9.6: Trends of the APAC Gene Synthesis Market ($B) by Application (2019-2026)
  • Figure 9.7: Forecast for the APAC Gene Synthesis Market ($B) by Application (2027-2035)
  • Figure 9.8: Trends and Forecast for the Japanese Gene Synthesis Market ($B) (2019-2035)
  • Figure 9.9: Trends and Forecast for the Indian Gene Synthesis Market ($B) (2019-2035)
  • Figure 9.10: Trends and Forecast for the Chinese Gene Synthesis Market ($B) (2019-2035)
  • Figure 9.11: Trends and Forecast for the South Korean Gene Synthesis Market ($B) (2019-2035)
  • Figure 9.12: Trends and Forecast for the Indonesian Gene Synthesis Market ($B) (2019-2035)
  • Figure 10.1: Trends and Forecast for the ROW Gene Synthesis Market (2019-2035)
  • Figure 10.2: ROW Gene Synthesis Market by Type in 2019, 2026, and 2035
  • Figure 10.3: Trends of the ROW Gene Synthesis Market ($B) by Type (2019-2026)
  • Figure 10.4: Forecast for the ROW Gene Synthesis Market ($B) by Type (2027-2035)
  • Figure 10.5: ROW Gene Synthesis Market by Application in 2019, 2026, and 2035
  • Figure 10.6: Trends of the ROW Gene Synthesis Market ($B) by Application (2019-2026)
  • Figure 10.7: Forecast for the ROW Gene Synthesis Market ($B) by Application (2027-2035)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Gene Synthesis Market ($B) (2019-2035)
  • Figure 10.9: Trends and Forecast for the South American Gene Synthesis Market ($B) (2019-2035)
  • Figure 10.10: Trends and Forecast for the African Gene Synthesis Market ($B) (2019-2035)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Gene Synthesis Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Gene Synthesis Market (2026)
  • Figure 12.1: Growth Opportunities for the Global Gene Synthesis Market by Type
  • Figure 12.2: Growth Opportunities for the Global Gene Synthesis Market by Application
  • Figure 12.3: Growth Opportunities for the Global Gene Synthesis Market by Region
  • Figure 12.4: Emerging Trends in the Global Gene Synthesis Market

List of Tables

  • Table 1.1: Growth Rate (%, 2024-2025) and CAGR (%, 2026-2035) of the Gene Synthesis Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Gene Synthesis Market by Region
  • Table 1.3: Global Gene Synthesis Market Parameters and Attributes
  • Table 3.1: Trends of the Global Gene Synthesis Market (2019-2025)
  • Table 3.2: Forecast for the Global Gene Synthesis Market (2026-2035)
  • Table 4.1: Attractiveness Analysis for the Global Gene Synthesis Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Gene Synthesis Market (2019-2025)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Gene Synthesis Market (2026-2035)
  • Table 4.4: Trends of Below 1000 bp in the Global Gene Synthesis Market (2019-2025)
  • Table 4.5: Forecast for Below 1000 bp in the Global Gene Synthesis Market (2026-2035)
  • Table 4.6: Trends of 1001-3000 bp in the Global Gene Synthesis Market (2019-2025)
  • Table 4.7: Forecast for 1001-3000 bp in the Global Gene Synthesis Market (2026-2035)
  • Table 4.8: Trends of 3001-5000 bp in the Global Gene Synthesis Market (2019-2025)
  • Table 4.9: Forecast for 3001-5000 bp in the Global Gene Synthesis Market (2026-2035)
  • Table 4.10: Trends of Above 5000 bp in the Global Gene Synthesis Market (2019-2025)
  • Table 4.11: Forecast for Above 5000 bp in the Global Gene Synthesis Market (2026-2035)
  • Table 5.1: Attractiveness Analysis for the Global Gene Synthesis Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Gene Synthesis Market (2019-2025)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Gene Synthesis Market (2026-2035)
  • Table 5.4: Trends of Commercial in the Global Gene Synthesis Market (2019-2025)
  • Table 5.5: Forecast for Commercial in the Global Gene Synthesis Market (2026-2035)
  • Table 5.6: Trends of Academic Research in the Global Gene Synthesis Market (2019-2025)
  • Table 5.7: Forecast for Academic Research in the Global Gene Synthesis Market (2026-2035)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Gene Synthesis Market (2019-2025)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Gene Synthesis Market (2026-2035)
  • Table 7.1: Trends of the North American Gene Synthesis Market (2019-2025)
  • Table 7.2: Forecast for the North American Gene Synthesis Market (2026-2035)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Gene Synthesis Market (2019-2025)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Gene Synthesis Market (2026-2035)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Gene Synthesis Market (2019-2025)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Gene Synthesis Market (2026-2035)
  • Table 7.7: Trends and Forecast for the United States Gene Synthesis Market (2019-2035)
  • Table 7.8: Trends and Forecast for the Mexican Gene Synthesis Market (2019-2035)
  • Table 7.9: Trends and Forecast for the Canadian Gene Synthesis Market (2019-2035)
  • Table 8.1: Trends of the European Gene Synthesis Market (2019-2025)
  • Table 8.2: Forecast for the European Gene Synthesis Market (2026-2035)
  • Table 8.3: Market Size and CAGR of Various Type in the European Gene Synthesis Market (2019-2025)
  • Table 8.4: Market Size and CAGR of Various Type in the European Gene Synthesis Market (2026-2035)
  • Table 8.5: Market Size and CAGR of Various Application in the European Gene Synthesis Market (2019-2025)
  • Table 8.6: Market Size and CAGR of Various Application in the European Gene Synthesis Market (2026-2035)
  • Table 8.7: Trends and Forecast for the German Gene Synthesis Market (2019-2035)
  • Table 8.8: Trends and Forecast for the French Gene Synthesis Market (2019-2035)
  • Table 8.9: Trends and Forecast for the Spanish Gene Synthesis Market (2019-2035)
  • Table 8.10: Trends and Forecast for the Italian Gene Synthesis Market (2019-2035)
  • Table 8.11: Trends and Forecast for the United Kingdom Gene Synthesis Market (2019-2035)
  • Table 9.1: Trends of the APAC Gene Synthesis Market (2019-2025)
  • Table 9.2: Forecast for the APAC Gene Synthesis Market (2026-2035)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Gene Synthesis Market (2019-2025)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Gene Synthesis Market (2026-2035)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Gene Synthesis Market (2019-2025)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Gene Synthesis Market (2026-2035)
  • Table 9.7: Trends and Forecast for the Japanese Gene Synthesis Market (2019-2035)
  • Table 9.8: Trends and Forecast for the Indian Gene Synthesis Market (2019-2035)
  • Table 9.9: Trends and Forecast for the Chinese Gene Synthesis Market (2019-2035)
  • Table 9.10: Trends and Forecast for the South Korean Gene Synthesis Market (2019-2035)
  • Table 9.11: Trends and Forecast for the Indonesian Gene Synthesis Market (2019-2035)
  • Table 10.1: Trends of the ROW Gene Synthesis Market (2019-2025)
  • Table 10.2: Forecast for the ROW Gene Synthesis Market (2026-2035)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Gene Synthesis Market (2019-2025)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Gene Synthesis Market (2026-2035)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Gene Synthesis Market (2019-2025)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Gene Synthesis Market (2026-2035)
  • Table 10.7: Trends and Forecast for the Middle Eastern Gene Synthesis Market (2019-2035)
  • Table 10.8: Trends and Forecast for the South American Gene Synthesis Market (2019-2035)
  • Table 10.9: Trends and Forecast for the African Gene Synthesis Market (2019-2035)
  • Table 11.1: Product Mapping of Gene Synthesis Suppliers Based on Segments
  • Table 11.2: Operational Integration of Gene Synthesis Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Gene Synthesis Revenue
  • Table 12.1: New Product Launches by Major Gene Synthesis Producers (2019-2025)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Gene Synthesis Market